Protection of prostatic acid phosphatase activity in human serum samples by plasmin inhibitors

Clinica Chimica Acta

Volumn 320, Issue 1-2, 2002, Pages 127-131

  Waheed, Abdul ^a   Van Etten, Robert L ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Plasmin inhibitors; Prostatic acid phosphatase; Stabilization of PAP in human serum

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; BENZYLSULFONYL FLUORIDE; PLASMIN; PLASMIN INHIBITOR; SERINE PROTEINASE INHIBITOR; TRYPSIN INHIBITOR;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD STORAGE; CANCER SCREENING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME PURIFICATION; ENZYME STABILITY; HUMAN; IMMUNOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTECTION; SEMINAL PLASMA; SERUM;

ANTIFIBRINOLYTIC AGENTS; BIOLOGICAL MARKERS; ENZYME STABILITY; HUMANS; MALE; MASS SCREENING; ORGAN SPECIFICITY; PROSTATE; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; PROTEIN DENATURATION; PROTEIN-TYROSINE-PHOSPHATASE; SPECIMEN HANDLING; TIME FACTORS;

BOVINAE;

EID: 0036241187     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00049-9     Document Type: Article

References (23)

1. Acid phosphatases
2. PSA and acid phosphatase in the diagnosis of prostate cancer
3. Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells
4. The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells
5. Sodium thymolphthalein monophosphate: A new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum
6. A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: Comparison with thymolphthalein phosphate
7. Immunochemical evaluation of the organ specificity of prostatic acid phosphatase
8. Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay
9. Counterimmunoelectrophoresis in determination of prostatic acid phosphatase in human serum
10. A solid phase fluorescent immunoassay for human prostatic acid phosphatase
11. The effect of antibody on human prostatic acid phosphatase
12. The effect of antibody on human prostatic acid phosphatase activity - I: Temperature and pH stabilization of acid phosphatase enzyme activity by rabbit antibody to acid phosphatase
13. Restoration of seminal acid phosphatase activity in presence of antibodies
14. Biosynthesis of prostatic acid phosphatase in a normal human cell-line
15. Biosynthesis and processing of prostatic and lysosomal acid phosphatases in a prostate carcinoma cell line PC-3SF12
16. Selective purification of tartrate-inhibitable acid phosphatase: Rapid and efficient purification (to homogeneity) of human and canine prostatic acid phosphatases
17. Immunological characterization of human acid phosphatase gene products
18. Human plasminogen and plasmin
19. Sulfonyl fluorides as inhibitors of esterases: II. Formation and reactions of phenylmethanesulfonyl α-chymotrypsin
20. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining
21. Plasminogen activator content of neoplastic and benign human prostate tissues; Fibrin augmentation of an activator activity
22. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model
23. Storage conditions for serum for estimating prostate-specific antigen